Abstract:Study question: What is the longitudinal association between gestational phthalate exposure and in vivo placental outcomes? Summary answer: Phthalates were adversely associated with placental microvasculature, stiffness, and presence of calcification, with different metabolites associated with different outcomes. What is known already: Phthalate exposure is ubiquitous and implicated as a contributor to adverse pregnancy outcomes, possibly through impacts on the placenta. Study design, size, duration: A total of 303 women were recruited in early pregnancy and prospectively followed for up to eight visits across gestation in the Human Placenta and Phthalates study. Participants/materials, setting, methods: At each visit, women provided urine samples and underwent placental ultrasounds. Urine was analyzed for 18 metabolites of phthalates and replacements. We took the geometric mean of repeated measurements to reflect pregnancy-averaged phthalate or replacement exposure for each participant (n = 303). Placental microvasculature, stiffness, and microcalcification presence were quantified from ultrasounds at each visit. Higher scores reflected worse placental function for all measures. Generalized linear mixed models were created to estimate the association between pregnancy-averaged exposure biomarker concentrations and repeated outcome measurements for microvasculature and stiffness. Gestational age at the time of calcification detection was modeled using Cox proportional hazards models. Main results and the role of chance: Monocarboxyisononyl phthalate and summed di(2-ethylhexyl) phthalate metabolites were associated with impaired microvasculature development, such that an interquartile range increase in concentration was associated with 0.11 standard deviation increase in the microvasculature ratio, indicating poorer vascularization (95% CI: 0.00, 0.22); 0.11 [95% CI: -0.01, 0.22], respectively. Monoethyl phthalate was associated with increased placental stiffness (0.09 [95% CI: -0.01, 0.19]) while summed di-iso-butyl phthalate metabolites and monobenzyl phthalate were associated with increased hazard of calcification detection (hazard ratios: 1.18 [95% CI: 0.98, 1.42]; 1.13 [95% CI: 0.96, 1.34]). Limitations, reasons for caution: Outcomes used in this study are novel and further investigation is needed to provide clinical context and relevance. Wider implications of the findings: We found evidence of associations between select phthalate biomarkers and various aspects of in vivo placental health, although we did not observe consistency across placental outcomes. These findings could illustrate heterogeneous effects of phthalate exposure on placental function. Study funding/competing interest(s): This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (ZIA ES103344), and NIEHS T32ES007018. The authors declare that they have no competing interests to disclose. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Use of trade names is for identification only and does not imply endorsement by the CDC, the Public Health Service, or the US Department of Health and Human Services. Trial registration number: N/A.

Lag associations of gestational phthalate exposure with maternal serum vitamin D levels: Repeated measure analysis

Maternal-neonatal Vitamin D Status and Related Factors

Effects of Prenatal Phthalate Exposure on Thyroid Hormone Concentrations Beginning at the Embryonic Stage

Relationship of individual and mixed prenatal phthalate exposure with placental structure and efficiency in the prospective Ma'anshan Birth Cohort Study

Urinary phthalate metabolites in pregnant women: occurrences, related factors, and association with maternal hormones

Variations of Phthalate Exposure and Metabolism over Three Trimesters.

Associations Between Phthalate Exposure and Thyroid Function in Pregnant Women During the First Trimester.

[Levels of Phthalate Internal Exposure Levels in Pregnant Women and Influencing Factors].

Effects of single and combined gestational phthalate exposure on blood pressure, blood glucose and gestational weight gain: A longitudinal analysis

Prenatal Exposure to Phthalates and Neurocognitive Development in Children at Two Years of Age

Longitudinal associations between urinary biomarkers of phthalates and replacements with novel in vivo measures of placental health

Association between prenatal phthalate exposure and gestational metabolic syndrome parameters: a systematic review of epidemiological studies

Gender associations between phthalate exposure and biomarkers of oxidative stress: A prospective cohort study

A Study on the Association of Placental and Maternal Urinary Phthalate Metabolites.

Combined effects of prenatal phthalate exposure on cardiometabolic risk score among 4- to 7-year-old children: MABC study

Exposure characteristics of phthalate metabolites among the Zunyi cohort of pregnant women in Southwest China

Urinary phthalate metabolites are associated with biomarkers of DNA damage and lipid peroxidation in pregnant women – Tainan Birth Cohort Study (TBCS)

Serum concentrations of phthalate metabolites in pregnant women and their association with gestational diabetes mellitus and blood glucose levels

Associations of pregnancy phthalate concentrations and their mixture with early adolescent bone mineral content and density: The Health Outcomes and Measures of the Environment (HOME) study

Lactational exposure to phthalates impaired the neurodevelopmental function of infants at 9 months in a pilot prospective study

Analyzing the impact of phthalate and DINCH exposure on fetal growth in a cohort with repeated urine collection